[Update in treatment of psoriatic arthritis]
Tunisie Medicale [La]. 2008; 86 (12): 1036-1041
in French
| IMEMR
| ID: emr-119712
ABSTRACT
Psoriatic arthritis is a chronic rheumatic disease making part of spondylarthropathies. It is the most frequent chronic inflammatory rheumatism after rheumatoid arthritis. Eventhough, it is usually a benign affection, it may be destructive leading to handicap. Several new medications have been introduced, including anti-tumor necrosis factor [TNF alpha blockers] and leflunomide for treatment of psoriatic arthritis. Many studies show the efficacy of these medications in this disease
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Tumor Necrosis Factor-alpha
/
Isoxazoles
/
Antibodies, Monoclonal
Limits:
Humans
Language:
French
Journal:
Tunisie Med.
Year:
2008
Similar
MEDLINE
...
LILACS
LIS